Epithelix announces LIVe2026 congress
It co-organizes with Altertox in Archamps, France, on Oct 8-9, 2026.
See the latest news and media coverage for Epithelix. We track all announcements, press releases, and industry mentions in real time, all in one place.
Provider of in vitro respiratory models
epithelix.comLast updated
In short: Epithelix prepared for its 20th anniversary conference, LIVe2026, while being recognized as a key player in the growing in vitro lung model market.
It co-organizes with Altertox in Archamps, France, on Oct 8-9, 2026.
The conference includes a gala dinner and abstract submission is open.
Dr. Shaun D. McCullough will speak on inhalation toxicity testing. Abstract and registration deadlines are set for July and August 2026.
Dedicated to viral exacerbations of asthma and COPD, it develops in vitro models alternative to animals to test innovative treatments. Funded by Auvergne-Rhône-Alpes Region, with Rheonova and RESPIVIR.
The research report on the global In-vitro Lung Model Market examines the current and future development estimates of the market. This report provides comprehensive information on the In-vitro Lung Model Market, which in the current market situation...
The global market for In Vitro Lung Model estimated at US$494.6 Million in the year 2022, is projected to reach a revised size of US$1.8...
Geneva - The PETA International Science Consortium Ltd. and Epithelix Sàrl are pleased to award three researchers three-dimensional tissue models that will be used to...
Track Epithelix and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.